lu aa24493
Recombinant proteinexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2007 (NCT00756249)
Timeline
Indications
Mechanism of action
- ErythropoietinSupplementation
EPO supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- lu aa24493
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01016366 | Phase 2 | Oct 1, 2009 | Lundbeck |
| NCT00870844 | Phase 1 | May 1, 2009 | Lundbeck |
| NCT00756249 | Phase 1 | Oct 1, 2007 | Lundbeck |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lundbeck | For profit | 3 | 3 | 2 | 2007 |
1 organizations
Page 1 / 1